The specific aims of this proposal are to identify clinical criteria, including specific diagnostic tests, which best identify those patients who would profit from corpus callosum section; to measure the callosotomy; to develop improved criteria to select patients for each of these procedures; and to determine the immediate and long-term clinical, neuropsychological, and electroencephalographic consequences of corpus callosotomy. Corpus callosotomy is a promising therapeutic modality for the approximately one million people with epilepsy in the United States who are medically intractable. All too many patients do not have a discrete epileptiform focus in a surgically resectable region, but do suffer from rapid secondary generalization and frequent injuries from the resultant falling seizures or loss of awareness. We have performed 10 complete corpus callosotomies to date with highly significant reductions in both post operative generalized epileptiform discharges and falling seizures. We expect 30 patients to be candidates for the corpus callosotomy procedure during the three year study period. We propose to perform 10 more complete sections to identify those critical EEG, clinical, and neuronpsychological criteria to allow us to perform 20 partial callosotomies in the remaining two years of the study. Success of therapy will be measured by reduction of seizure frequency, ability to simplify antiepileptic medication regimens, and evidence of increased independence in daily living. Neuropsyhological effects will be studied in a separate proposal. Appropriate statistical analysis will be used as outlined in detail in the proposal.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS016308-07A1
Application #
3107701
Study Section
Neurological Disorders Program Project Review B Committee (NSPB)
Project Start
1980-07-01
Project End
1991-07-31
Budget Start
1986-08-01
Budget End
1987-07-31
Support Year
7
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Overall Medical
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Conway, Jeannine M; Eberly, Lynn E; Collins, Joseph F et al. (2017) Factors in Variability of Serial Gabapentin Concentrations in Elderly Patients with Epilepsy. Pharmacotherapy 37:1197-1203
Polepally, Akshanth R; Remmel, Rory P; Brundage, Richard C et al. (2015) Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology. J Clin Pharmacol 55:1101-8
Patel, Sima I; Birnbaum, Angela K; Cloyd, James C et al. (2015) Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy. CNS Drugs 29:1009-22
Conway, Jeannine M; Birnbaum, Angela K; Leppik, Ilo E et al. (2014) Safety of an intravenous formulation of lamotrigine. Seizure 23:390-2
Ghodke-Puranik, Yogita; Thorn, Caroline F; Lamba, Jatinder K et al. (2013) Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics 23:236-41
Ahmed, Ghada F; Brundage, Richard C; Marino, Susan E et al. (2013) Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy. J Clin Pharmacol 53:276-84
Puranik, Yogita Ghodke; Birnbaum, Angela K; Marino, Susan E et al. (2013) Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Pharmacogenomics 14:35-45
Conway, Jeannine M; Birnbaum, Angela K; Marino, Susan E et al. (2012) A sensitive capillary GC-MS method for analysis of topiramate from plasma obtained from single-dose studies. Biomed Chromatogr 26:1071-6
Punyawudho, Baralee; Ramsay, Eugene R; Brundage, Richard C et al. (2012) Population pharmacokinetics of carbamazepine in elderly patients. Ther Drug Monit 34:176-81
Marino, S E; Birnbaum, A K; Leppik, I E et al. (2012) Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex. Clin Pharmacol Ther 91:483-8

Showing the most recent 10 out of 96 publications